Unknown

Dataset Information

0

Long-term restoration of cardiac dystrophin expression in golden retriever muscular dystrophy following rAAV6-mediated exon skipping.


ABSTRACT: Although restoration of dystrophin expression via exon skipping in both cardiac and skeletal muscle has been successfully demonstrated in the mdx mouse, restoration of cardiac dystrophin expression in large animal models of Duchenne muscular dystrophy (DMD) has proven to be a challenge. In large animals, investigators have focused on using intravenous injection of antisense oligonucleotides (AO) to mediate exon skipping. In this study, we sought to optimize restoration of cardiac dystrophin expression in the golden retriever muscular dystrophy (GRMD) model using percutaneous transendocardial delivery of recombinant AAV6 (rAAV6) to deliver a modified U7 small nuclear RNA (snRNA) carrying antisense sequence to target the exon splicing enhancers of exons 6 and 8 and correct the disrupted reading frame. We demonstrate restoration of cardiac dystrophin expression at 13 months confirmed by reverse transcription-PCR (RT-PCR) and immunoblot as well as membrane localization by immunohistochemistry. This was accompanied by improved cardiac function as assessed by cardiac magnetic resonance imaging (MRI). Percutaneous transendocardial delivery of rAAV6 expressing a modified U7 exon skipping construct is a safe, effective method for restoration of dystrophin expression and improvement of cardiac function in the GRMD canine and may be easily translatable to human DMD patients.

SUBMITTER: Bish LT 

PROVIDER: S-EPMC3293605 | biostudies-literature | 2012 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications


Although restoration of dystrophin expression via exon skipping in both cardiac and skeletal muscle has been successfully demonstrated in the mdx mouse, restoration of cardiac dystrophin expression in large animal models of Duchenne muscular dystrophy (DMD) has proven to be a challenge. In large animals, investigators have focused on using intravenous injection of antisense oligonucleotides (AO) to mediate exon skipping. In this study, we sought to optimize restoration of cardiac dystrophin expr  ...[more]

Similar Datasets

| S-EPMC3498802 | biostudies-other
| S-EPMC3277241 | biostudies-literature
| S-EPMC3107769 | biostudies-literature
| S-EPMC4373433 | biostudies-literature
| S-EPMC5438519 | biostudies-literature
| S-EPMC8673534 | biostudies-literature
| S-EPMC8657897 | biostudies-literature
| S-SCDT-10_1038-S44321-024-00031-3 | biostudies-other
| S-EPMC3124804 | biostudies-literature
| S-EPMC3156980 | biostudies-literature